{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:28:55Z","timestamp":1787020135843,"version":"build-2736575974"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"DOI":"10.13039\/501100000975","name":"Kidney Health Australia","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100000975","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100011093","name":"Shire Australia","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100011093","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Pathology Queensland"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s12882-017-0705-4","type":"journal-article","created":{"date-parts":[[2017,9,4]],"date-time":"2017-09-04T08:03:33Z","timestamp":1504512213000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":31,"title":["Progression of arterial stiffness is associated with changes in bone mineral markers in advanced CKD"],"prefix":"10.1186","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6974-7880","authenticated-orcid":false,"given":"Rathika","family":"Krishnasamy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sven-Jean","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmel M.","family":"Hawley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David W.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tony","family":"Stanton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David W.","family":"Mudge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott","family":"Campbell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grahame J.","family":"Elder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nigel D.","family":"Toussaint","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole M.","family":"Isbel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,9,4]]},"reference":[{"issue":"7","key":"705_CR1","doi-asserted-by":"publisher","first-page":"2034","DOI":"10.1681\/ASN.2005101085","volume":"17","author":"M Tonelli","year":"2006","unstructured":"Tonelli M, Wiebe N, Culleton B, House A, Rabbat C, Fok M, McAlister F, Garg AX. Chronic kidney disease and mortality risk: a systematic review. J Am Soc Nephrol. 2006;17(7):2034\u201347.","journal-title":"J Am Soc Nephrol"},{"issue":"3","key":"705_CR2","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1038\/sj.ki.5001589","volume":"70","author":"JP Schwaiger","year":"2006","unstructured":"Schwaiger JP, Neyer U, Sprenger-Mahr H, Kollerits B, Mundle M, Langle M, Kronenberg F. A simple score predicts future cardiovascular events in an inception cohort of dialysis patients. Kidney Int. 2006;70(3):543\u20138.","journal-title":"Kidney Int"},{"issue":"23","key":"705_CR3","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1016\/j.jacc.2009.02.047","volume":"53","author":"FG Hage","year":"2009","unstructured":"Hage FG, Venkataraman R, Zoghbi GJ, Perry GJ, DeMattos AM, Iskandrian AE. The scope of coronary heart disease in patients with chronic kidney disease. J Am Coll Cardiol. 2009;53(23):2129\u201340.","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"705_CR4","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1161\/HYPERTENSIONAHA.112.197210","volume":"60","author":"A Karras","year":"2012","unstructured":"Karras A, Haymann JP, Bozec E, Metzger M, Jacquot C, Maruani G, Houillier P, Froissart M, Stengel B, Guardiola P, et al. Large artery stiffening and remodeling are independently associated with all-cause mortality and cardiovascular events in chronic kidney disease. Hypertension. 2012;60(6):1451\u20137.","journal-title":"Hypertension"},{"issue":"12","key":"705_CR5","doi-asserted-by":"publisher","first-page":"2959","DOI":"10.1097\/01.ASN.0000145894.57533.C4","volume":"15","author":"CM Giachelli","year":"2004","unstructured":"Giachelli CM. Vascular calcification mechanisms. Journal of the American Society of Nephrology : JASN. 2004;15(12):2959\u201364.","journal-title":"Journal of the American Society of Nephrology : JASN"},{"issue":"5","key":"705_CR6","doi-asserted-by":"publisher","first-page":"1724","DOI":"10.1046\/j.1523-1755.2002.00625.x","volume":"62","author":"NX Chen","year":"2002","unstructured":"Chen NX, O'Neill KD, Duan D, Moe SM. Phosphorus and uremic serum up-regulate osteopontin expression in vascular smooth muscle cells. Kidney Int. 2002;62(5):1724\u201331.","journal-title":"Kidney Int"},{"issue":"2","key":"705_CR7","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1046\/j.1523-1755.2002.00170.x","volume":"61","author":"SM Moe","year":"2002","unstructured":"Moe SM, O'Neill KD, Duan D, Ahmed S, Chen NX, Leapman SB, Fineberg N, Kopecky K. Medial artery calcification in ESRD patients is associated with deposition of bone matrix proteins. Kidney Int. 2002;61(2):638\u201347.","journal-title":"Kidney Int"},{"issue":"39","key":"705_CR8","doi-asserted-by":"publisher","first-page":"37419","DOI":"10.1074\/jbc.M304544200","volume":"278","author":"S Liu","year":"2003","unstructured":"Liu S, Guo R, Simpson LG, Xiao ZS, Burnham CE, Quarles LD. Regulation of fibroblastic growth factor 23 expression but not degradation by PHEX. J Biol Chem. 2003;278(39):37419\u201326.","journal-title":"J Biol Chem"},{"issue":"6","key":"705_CR9","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.1681\/ASN.2007010068","volume":"18","author":"S Liu","year":"2007","unstructured":"Liu S, Quarles LD. How fibroblast growth factor 23 works. J Am Soc Nephrol. 2007;18(6):1637\u201347.","journal-title":"J Am Soc Nephrol"},{"issue":"10","key":"705_CR10","doi-asserted-by":"publisher","first-page":"2683","DOI":"10.1681\/ASN.2006070783","volume":"18","author":"T Kawata","year":"2007","unstructured":"Kawata T, Imanishi Y, Kobayashi K, Miki T, Arnold A, Inaba M, Nishizawa Y. Parathyroid hormone regulates fibroblast growth factor-23 in a mouse model of primary hyperparathyroidism. J Am Soc Nephrol. 2007;18(10):2683\u20138.","journal-title":"J Am Soc Nephrol"},{"issue":"4","key":"705_CR11","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1172\/JCI200419081","volume":"113","author":"T Shimada","year":"2004","unstructured":"Shimada T, Kakitani M, Yamazaki Y, Hasegawa H, Takeuchi Y, Fujita T, Fukumoto S, Tomizuka K, Yamashita T. Targeted ablation of Fgf23 demonstrates an essential physiological role of FGF23 in phosphate and vitamin D metabolism. J Clin Invest. 2004;113(4):561\u20138.","journal-title":"J Clin Invest"},{"issue":"4","key":"705_CR12","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1093\/ndt\/gfl718","volume":"22","author":"L Craver","year":"2007","unstructured":"Craver L, Marco MP, Martinez I, Rue M, Borras M, Martin ML, Sarro F, Valdivielso JM, Fernandez E. Mineral metabolism parameters throughout chronic kidney disease stages 1-5--achievement of K\/DOQI target ranges. Nephrol Dial Transplant. 2007;22(4):1171\u20136.","journal-title":"Nephrol Dial Transplant"},{"issue":"4","key":"705_CR13","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1006\/bbrc.2000.4226","volume":"280","author":"N Koh","year":"2001","unstructured":"Koh N, Fujimori T, Nishiguchi S, Tamori A, Shiomi S, Nakatani T, Sugimura K, Kishimoto T, Kinoshita S, Kuroki T, et al. Severely reduced production of klotho in human chronic renal failure kidney. Biochem Biophys Res Commun. 2001;280(4):1015\u201320.","journal-title":"Biochem Biophys Res Commun"},{"issue":"8","key":"705_CR14","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1111\/nep.12268","volume":"19","author":"SJ Tan","year":"2014","unstructured":"Tan SJ, Smith ER, Hewitson TD, Holt SG, Toussaint ND. The importance of klotho in phosphate metabolism and kidney disease. Nephrology. 2014;19(8):439\u201349.","journal-title":"Nephrology"},{"issue":"2","key":"705_CR15","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1159\/000331737","volume":"28","author":"M Dermaku-Sopjani","year":"2011","unstructured":"Dermaku-Sopjani M, Sopjani M, Saxena A, Shojaiefard M, Bogatikov E, Alesutan I, Eichenmuller M, Lang F. Downregulation of NaPi-IIa and NaPi-IIb Na-coupled phosphate transporters by coexpression of klotho. Cell Physiol Biochem. 2011;28(2):251\u20138.","journal-title":"Cell Physiol Biochem"},{"issue":"3","key":"705_CR16","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1016\/j.bbrc.2005.11.094","volume":"339","author":"M Ikushima","year":"2006","unstructured":"Ikushima M, Rakugi H, Ishikawa K, Maekawa Y, Yamamoto K, Ohta J, Chihara Y, Kida I, Ogihara T. Anti-apoptotic and anti-senescence effects of klotho on vascular endothelial cells. Biochem Biophys Res Commun. 2006;339(3):827\u201332.","journal-title":"Biochem Biophys Res Commun"},{"issue":"5","key":"705_CR17","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1038\/ki.2013.332","volume":"85","author":"R Jimbo","year":"2014","unstructured":"Jimbo R, Kawakami-Mori F, Mu S, Hirohama D, Majtan B, Shimizu Y, Yatomi Y, Fukumoto S, Fujita T, Shimosawa T. Fibroblast growth factor 23 accelerates phosphate-induced vascular calcification in the absence of klotho deficiency. Kidney Int. 2014;85(5):1103\u201311.","journal-title":"Kidney Int"},{"key":"705_CR18","volume-title":"The active Australia survey: a guide andmanual for implementation, analysis and reporting","author":"Welfare AIoHa","year":"2003","unstructured":"Welfare AIoHa. The active Australia survey: a guide andmanual for implementation, analysis and reporting. In: AIHW, editor. . Canberra: Australian Institute of Health and Welfare; 2003."},{"issue":"8","key":"705_CR19","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1249\/mss.0b013e3180616aa2","volume":"39","author":"ME Nelson","year":"2007","unstructured":"Nelson ME, Rejeski WJ, Blair SN, Duncan PW, Judge JO, King AC, Macera CA, Castaneda-Sceppa C. Physical activity and public health in older adults: recommendation from the American College of Sports Medicine and the American Heart Association. Med Sci Sports Exerc. 2007;39(8):1435\u201345.","journal-title":"Med Sci Sports Exerc"},{"issue":"9","key":"705_CR20","doi-asserted-by":"publisher","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","volume":"150","author":"AS Levey","year":"2009","unstructured":"Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF 3rd, Feldman HI, Kusek JW, Eggers P, Van Lente F, Greene T, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150(9):604\u201312.","journal-title":"Ann Intern Med"},{"issue":"5","key":"705_CR21","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1161\/01.HYP.33.5.1111","volume":"33","author":"J Blacher","year":"1999","unstructured":"Blacher J, Asmar R, Djane S, London GM, Safar ME. Aortic pulse wave velocity as a marker of cardiovascular risk in hypertensive patients. Hypertension. 1999;33(5):1111\u20137.","journal-title":"Hypertension"},{"issue":"3","key":"705_CR22","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1097\/HJH.0b013e32834fa8b0","volume":"30","author":"LM Bortel Van","year":"2012","unstructured":"Van Bortel LM, Laurent S, Boutouyrie P, Chowienczyk P, Cruickshank JK, De Backer T, Filipovsky J, Huybrechts S, Mattace-Raso FU, Protogerou AD, et al. Expert consensus document on the measurement of aortic stiffness in daily practice using carotid-femoral pulse wave velocity. J Hypertens. 2012;30(3):445\u20138.","journal-title":"J Hypertens"},{"issue":"2","key":"705_CR23","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/S0021-9150(97)00106-8","volume":"132","author":"LI Kauppila","year":"1997","unstructured":"Kauppila LI, Polak JF, Cupples LA, Hannan MT, Kiel DP, Wilson PW. New indices to classify location, severity and progression of calcific lesions in the abdominal aorta: a 25-year follow-up study. Atherosclerosis. 1997;132(2):245\u201350.","journal-title":"Atherosclerosis"},{"issue":"13","key":"705_CR24","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1016\/j.jacc.2009.10.061","volume":"55","author":"C Vlachopoulos","year":"2010","unstructured":"Vlachopoulos C, Aznaouridis K, Stefanadis C. Prediction of cardiovascular events and all-cause mortality with arterial stiffness: a systematic review and meta-analysis. J Am Coll Cardiol. 2010;55(13):1318\u201327.","journal-title":"J Am Coll Cardiol"},{"issue":"18","key":"705_CR25","doi-asserted-by":"publisher","first-page":"2434","DOI":"10.1161\/01.CIR.99.18.2434","volume":"99","author":"J Blacher","year":"1999","unstructured":"Blacher J, Guerin AP, Pannier B, Marchais SJ, Safar ME, London GM. Impact of aortic stiffness on survival in end-stage renal disease. Circulation. 1999;99(18):2434\u20139.","journal-title":"Circulation"},{"issue":"12","key":"705_CR26","doi-asserted-by":"publisher","first-page":"4041","DOI":"10.1093\/ndt\/gfq293","volume":"25","author":"JY Jung","year":"2010","unstructured":"Jung JY, Hwang YH, Lee SW, Lee H, Kim DK, Kim S, Oh YG, Yang J, Joo KW, Ahn C, et al. Factors associated with aortic stiffness and its change over time in peritoneal dialysis patients. Nephrol Dial Transplant. 2010;25(12):4041\u20138.","journal-title":"Nephrol Dial Transplant"},{"issue":"11","key":"705_CR27","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1111\/jch.12198","volume":"15","author":"S Tholen","year":"2013","unstructured":"Tholen S, Klofat K, Pan CR, Schmaderer C, Lutz J, Heemann U, Baumann M. Progression of aortic pulse wave velocity in patients with chronic kidney disease. J Clin Hypertens. 2013;15(11):833\u20138.","journal-title":"J Clin Hypertens"},{"issue":"2","key":"705_CR28","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/j.atherosclerosis.2009.01.001","volume":"205","author":"MA Mirza","year":"2009","unstructured":"Mirza MA, Larsson A, Lind L, Larsson TE. Circulating fibroblast growth factor-23 is associated with vascular dysfunction in the community. Atherosclerosis. 2009;205(2):385\u201390.","journal-title":"Atherosclerosis"},{"issue":"6","key":"705_CR29","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1038\/ki.2013.3","volume":"83","author":"JJ Scialla","year":"2013","unstructured":"Scialla JJ, Lau WL, Reilly MP, Isakova T, Yang HY, Crouthamel MH, Chavkin NW, Rahman M, Wahl P, Amaral AP, et al. Fibroblast growth factor 23 is not associated with and does not induce arterial calcification. Kidney Int. 2013;83(6):1159\u201368.","journal-title":"Kidney Int"},{"issue":"7","key":"705_CR30","doi-asserted-by":"publisher","first-page":"2017","DOI":"10.1007\/s00198-011-1838-0","volume":"23","author":"L Desjardins","year":"2012","unstructured":"Desjardins L, Liabeuf S, Renard C, Lenglet A, Lemke HD, Choukroun G, Drueke TB, Massy ZA. European uremic toxin work G: FGF23 is independently associated with vascular calcification but not bone mineral density in patients at various CKD stages. Osteoporos Int. 2012;23(7):2017\u201325.","journal-title":"Osteoporos Int"},{"key":"705_CR31","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1186\/1471-2369-14-241","volume":"14","author":"A Ozkok","year":"2013","unstructured":"Ozkok A, Kekik C, Karahan GE, Sakaci T, Ozel A, Unsal A, Yildiz A. FGF-23 associated with the progression of coronary artery calcification in hemodialysis patients. BMC Nephrol. 2013;14:241.","journal-title":"BMC Nephrol"},{"issue":"11","key":"705_CR32","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1038\/ki.2009.24","volume":"75","author":"M Ohnishi","year":"2009","unstructured":"Ohnishi M, Nakatani T, Lanske B, Razzaque MS. Reversal of mineral ion homeostasis and soft-tissue calcification of klotho knockout mice by deletion of vitamin D 1alpha-hydroxylase. Kidney Int. 2009;75(11):1166\u201372.","journal-title":"Kidney Int"},{"issue":"6655","key":"705_CR33","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/36285","volume":"390","author":"M Kuro-o","year":"1997","unstructured":"Kuro-o M, Matsumura Y, Aizawa H, Kawaguchi H, Suga T, Utsugi T, Ohyama Y, Kurabayashi M, Kaname T, Kume E, et al. Mutation of the mouse klotho gene leads to a syndrome resembling ageing. Nature. 1997;390(6655):45\u201351.","journal-title":"Nature"},{"issue":"5","key":"705_CR34","doi-asserted-by":"publisher","first-page":"E426","DOI":"10.1152\/ajpendo.00264.2014","volume":"307","author":"N Silswal","year":"2014","unstructured":"Silswal N, Touchberry CD, Daniel DR, McCarthy DL, Zhang S, Andresen J, Stubbs JR, Wacker MJ. FGF23 directly impairs endothelium-dependent vasorelaxation by increasing superoxide levels and reducing nitric oxide bioavailability. Am J Phys Endocrinol Metab. 2014;307(5):E426\u201336.","journal-title":"Am J Phys Endocrinol Metab"},{"issue":"8","key":"705_CR35","doi-asserted-by":"publisher","first-page":"E863","DOI":"10.1152\/ajpendo.00596.2012","volume":"304","author":"CD Touchberry","year":"2013","unstructured":"Touchberry CD, Green TM, Tchikrizov V, Mannix JE, Mao TF, Carney BW, Girgis M, Vincent RJ, Wetmore LA, Dawn B, et al. FGF23 is a novel regulator of intracellular calcium and cardiac contractility in addition to cardiac hypertrophy. Am J Phys Endocrinol Metab. 2013;304(8):E863\u201373.","journal-title":"Am J Phys Endocrinol Metab"},{"issue":"11","key":"705_CR36","doi-asserted-by":"publisher","first-page":"4393","DOI":"10.1172\/JCI46122","volume":"121","author":"C Faul","year":"2011","unstructured":"Faul C, Amaral AP, Oskouei B, Hu MC, Sloan A, Isakova T, Gutierrez OM, Aguillon-Prada R, Lincoln J, Hare JM, et al. FGF23 induces left ventricular hypertrophy. J Clin Invest. 2011;121(11):4393\u2013408.","journal-title":"J Clin Invest"},{"issue":"7","key":"705_CR37","doi-asserted-by":"publisher","first-page":"2543","DOI":"10.1172\/JCI61405","volume":"122","author":"V Shalhoub","year":"2012","unstructured":"Shalhoub V, Shatzen EM, Ward SC, Davis J, Stevens J, Bi V, Renshaw L, Hawkins N, Wang W, Chen C, et al. FGF23 neutralization improves chronic kidney disease-associated hyperparathyroidism yet increases mortality. J Clin Invest. 2012;122(7):2543\u201353.","journal-title":"J Clin Invest"},{"issue":"3\u20134","key":"705_CR38","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1159\/000353593","volume":"123","author":"CP Kovesdy","year":"2013","unstructured":"Kovesdy CP, Quarles LD. The role of fibroblast growth factor-23 in cardiorenal syndrome. Nephron Clinical practice. 2013;123(3\u20134):194\u2013201.","journal-title":"Nephron Clinical practice"},{"issue":"9","key":"705_CR39","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0044161","volume":"7","author":"B Dai","year":"2012","unstructured":"Dai B, David V, Martin A, Huang J, Li H, Jiao Y, Gu W, Quarles LD. A comparative transcriptome analysis identifying FGF23 regulated genes in the kidney of a mouse CKD model. PLoS One. 2012;7(9):e44161.","journal-title":"PLoS One"},{"issue":"Pt 2","key":"705_CR40","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1177\/0004563213510708","volume":"51","author":"ER Smith","year":"2014","unstructured":"Smith ER, McMahon LP, Holt SG. Fibroblast growth factor 23. Ann Clin Biochem. 2014;51(Pt 2):203\u201327.","journal-title":"Ann Clin Biochem"},{"issue":"3","key":"705_CR41","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1111\/j.1474-9726.2012.00796.x","volume":"11","author":"Y Wang","year":"2012","unstructured":"Wang Y, Kuro-o M, Sun Z. Klotho gene delivery suppresses Nox2 expression and attenuates oxidative stress in rat aortic smooth muscle cells via the cAMP-PKA pathway. Aging Cell. 2012;11(3):410\u20137.","journal-title":"Aging Cell"},{"issue":"2","key":"705_CR42","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1006\/bbrc.1998.8943","volume":"248","author":"Y Saito","year":"1998","unstructured":"Saito Y, Yamagishi T, Nakamura T, Ohyama Y, Aizawa H, Suga T, Matsumura Y, Masuda H, Kurabayashi M, Kuro-o M, et al. Klotho protein protects against endothelial dysfunction. Biochem Biophys Res Commun. 1998;248(2):324\u20139.","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"705_CR43","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1681\/ASN.2009121311","volume":"22","author":"MC Hu","year":"2011","unstructured":"Hu MC, Shi M, Zhang J, Quinones H, Griffith C, Kuro-o M, Moe OW. Klotho deficiency causes vascular calcification in chronic kidney disease. Journal of the American Society of Nephrology : JASN. 2011;22(1):124\u201336.","journal-title":"Journal of the American Society of Nephrology : JASN"},{"issue":"1","key":"705_CR44","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1136\/heartjnl-2013-304746","volume":"100","author":"JF Navarro-Gonzalez","year":"2014","unstructured":"Navarro-Gonzalez JF, Donate-Correa J, Muros de Fuentes M, Perez-Hernandez H, Martinez-Sanz R, Mora-Fernandez C. Reduced klotho is associated with the presence and severity of coronary artery disease. Heart. 2014;100(1):34\u201340.","journal-title":"Heart"},{"issue":"2","key":"705_CR45","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0056695","volume":"8","author":"M Kitagawa","year":"2013","unstructured":"Kitagawa M, Sugiyama H, Morinaga H, Inoue T, Takiue K, Ogawa A, Yamanari T, Kikumoto Y, Uchida HA, Kitamura S, et al. A decreased level of serum soluble klotho is an independent biomarker associated with arterial stiffness in patients with chronic kidney disease. PLoS One. 2013;8(2):e56695.","journal-title":"PLoS One"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-017-0705-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,9,10]],"date-time":"2018-09-10T09:06:09Z","timestamp":1536570369000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcnephrol.biomedcentral.com\/articles\/10.1186\/s12882-017-0705-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9,4]]},"references-count":45,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["705"],"URL":"https:\/\/doi.org\/10.1186\/s12882-017-0705-4","relation":{},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,9,4]]},"article-number":"281"}}